MARKER THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
MARKER THERAPEUTICS, INC. (MRKR) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $1.41 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.41.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.04.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.59.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $1.59.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $1.41 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $1.04 10-K · filed 2026-03-18 | |
| 2025-09-30 | $1.59 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.59 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.59 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $1.99 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.99 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.99 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.15 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $4.70 10-K · filed 2024-03-26 | |
| 2022-09-30 | $0.47 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $0.48 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $0.51 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $29.00 10-K · filed 2023-03-22 | $2.90 10-K · filed 2022-03-17 |
| 2021-09-30 | $3.05 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.06 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $3.12 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.08 10-K · filed 2022-03-17 | |
| 2020-09-30 | $2.13 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.13 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.14 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $4.70 10-K · filed 2021-03-09 | |
| 2018-12-31 | $8.89 10-K · filed 2020-03-12 | |
| 2017-12-31 | $3.25 10-K · filed 2019-03-15 | |
| 2016-12-31 | $5.84 10-K · filed 2018-03-23 | |
| 2015-12-31 | $6.65 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |